Combination of checkpoint inhibitors with radiotherapy in esophageal squamous cell carcinoma treatment: A novel strategy

Despite the rapid development of numerous types of treatment, including radiotherapy (RT) as the main strategy, esophageal squamous cell carcinoma (ESCC) has a poor prognosis. Recent studies demonstrated that immunotherapy can improve the survival of patients with locally advanced and metastatic ESC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xiu-Yong, Liu, Chao-Yuan, He, Jian-Feng, Wang, Li-Shu, Zhang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781725/
https://www.ncbi.nlm.nih.gov/pubmed/31612012
http://dx.doi.org/10.3892/ol.2019.10893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781725/
https://www.ncbi.nlm.nih.gov/pubmed/31612012
http://dx.doi.org/10.3892/ol.2019.10893

Ejemplares similares